ACUREX BIOSCIENCES Trademark

Trademark Overview

On Monday, December 21, 2020, a trademark application was filed for ACUREX BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the ACUREX BIOSCIENCES trademark a serial number of 90397151. The federal status of this trademark filing is PETITION TO REVIVE - RECEIVED as of Tuesday, October 21, 2025. This trademark is owned by AcureX Therapeutics Corporation. The ACUREX BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, diagnostic biomarker reagents and assays for detection of Parkinson's Disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases
acurex biosciences

General Information

Serial Number90397151
Word MarkACUREX BIOSCIENCES
Filing DateMonday, December 21, 2020
Status612 - PETITION TO REVIVE - RECEIVED
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, diagnostic biomarker reagents and assays for detection of Parkinson's Disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases
NOT AVAILABLEBIOSCIENCES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACUREX BIOSCIENCES CORPORATION
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 94070
Party NameAcureX Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Carolos, CA 94070
Party NameAcureX Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carolos, CA 94070

Trademark Events

Event DateEvent Description
Thursday, December 24, 2020NEW APPLICATION ENTERED
Thursday, March 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 16, 2021ASSIGNED TO EXAMINER
Saturday, June 19, 2021PRIORITY ACTION WRITTEN
Saturday, June 19, 2021PRIORITY ACTION E-MAILED
Saturday, June 19, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, September 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, April 21, 2022OPPOSITION INSTITUTED NO. 999999
Monday, February 13, 2023OPPOSITION DISMISSED NO. 999999
Monday, February 13, 2023OPPOSITION TERMINATED NO. 999999
Monday, February 13, 2023TTAB RELEASE CASE TO TRADEMARKS
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 1 FILED
Monday, July 17, 2023SOU EXTENSION 1 GRANTED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024SOU EXTENSION 2 FILED
Wednesday, March 13, 2024SOU EXTENSION 2 GRANTED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 29, 2024SOU TEAS EXTENSION RECEIVED
Sunday, September 29, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 17, 2025REVIEW OF CORRESPONDENCE COMPLETE
Sunday, September 29, 2024DIVISIONAL REQUEST RECEIVED
Friday, January 17, 2025DIVISIONAL PROCESSING COMPLETE
Sunday, September 29, 2024SOU EXTENSION 3 FILED
Friday, January 17, 2025SOU EXTENSION 3 GRANTED
Saturday, January 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2025CORRECTED NOA E-MAILED
Wednesday, February 5, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 14, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 14, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, October 21, 2025TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 21, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION

Related Keywords

biosciences acurex diseases mitochondrial pharmaceutical preparations disease parkinson medical diagnostic aging huntington